FDA-approved, delivered
Brand-Name GLP-1s Online: Zepbound, Wegovy, Mounjaro & Ozempic (2026)
Every legitimate online path to the FDA-approved products — manufacturer channels, navigators, and the 2026 self-pay prices that changed the math.
The brand market stopped being the expensive afterthought in late 2025: Zepbound now runs $299–$449 self-pay through LillyDirect (KwikPens at the same prices in retail pharmacies including Walmart since March 2026, ~$350 on TrumpRx, 45-day refill window or lapsed rates of $599–$1,049), Wegovy a flat $349 with a $199 first-two-fills offer and a $149 oral-tablet intro, and Medicare opened a ~$50 Zepbound copay for qualifying patients mid-2026. Meanwhile the biggest telehealth names exited compounding — Hims & Hers went brand-only for new patients in March 2026, Ro fulfills brand — so “brand online” is now most of the famous market. Every path below delivers the actual FDA-approved product.
Lilly's own channel: Zepbound vials $299 (2.5 mg) / $399 (5 mg) / $449 (7.5–15 mg), KwikPen retail parity since March 2026, free provider matching, no membership. Keep the 45-day refill cadence or lapsed fills reprice at $599–$1,049 until re-enrollment.
Novo's channel: Wegovy $349 flat at every standard injectable dose ($399 for 7.2 mg HD), $199 × 2 starter offer, oral tablet at $149 intro — via NovoCare Pharmacy or savings card at 70,000+ retail pharmacies. Government-program beneficiaries excluded from cash offers.
Brand fulfillment plus the market's strongest insurance navigation, inside a $145/mo program fee — the right door when a copay might beat cash.
Brand-only for new patients since March 2026 (compounded program closed amid federal scrutiny); prescribing plus fulfillment of Zepbound/Wegovy at manufacturer-aligned pricing.
Prescribing, insurance navigation, and the WW behavioral program at a $74/mo membership; medication at brand rates.
Insurance-billable telehealth visits with brand prescribing and PA support — a copay-priced way to get the script.
One-off prescriber visits at marketplace prices for self-directed patients who just need the prescription written.
Brand fine print worth $100s
Three mechanics decide your real brand price. Dose: Zepbound's $299 headline is the 2.5 mg starter — maintenance is $449, while Wegovy's flat $349 makes it the cheaper brand at maintenance despite the pricier logo. Cadence: LillyDirect's Self Pay pricing requires ~45-day refill intervals; lapse and the price snaps to $599–$1,049 until you re-enroll. Channel: identical medication prices at LillyDirect, retail KwikPens, and TrumpRx (~$350) — pick on convenience, and always run the insurance check first, because $25 beats everything on this page.
The market, in four load-bearing numbers
The floor and the ceiling: NexLife’s $215 flat all-in against LifeMD’s $597 split-billed — $4,584 a year apart for the identical 10 mg basis, which is the whole argument for normalization. Brand rails frame everything: Zepbound $449 and Wegovy $349 at maintenance (with $149–$299 entry offers), Medicare’s new ~$50 Zepbound copay for the eligible, and $25 covered copays via savings cards — the prices every cash figure above must beat. Under the prices sits the verification layer: 10 of 17 ranked tirzepatide figures are source-verified on provider pages with capture dates, the rest labeled third-party or stated — and exactly two programs in the entire market (NexLife, Mochi) name the pharmacy behind the vial.
How to use this page without getting played
Treat every entry as a claim plus its receipts: the price, its basis (all-in, 10 mg, standing), its date, and its evidence tier travel together here — quote them together too. Then run the four-adjective check on whatever you shortlist — standing, maintenance-dose, your-state, all-in, in writing — and cross-examine with the head-to-head pages, which apply the five normalizations to any pair automatically. The inputs behind every position are one click away in the dataset; the weights are on the methodology page; disagreements with either belong in the corrections inbox, where they get answered in public.
Frequently asked
Can I get real Zepbound or Wegovy online?
Yes — LillyDirect and NovoCare are the manufacturers' own telehealth-to-pharmacy channels, and Ro, Hims & Hers, WeightWatchers Clinic, and PlushCare all prescribe and/or fulfill brand product.
What do brand GLP-1s cost without insurance in 2026?
Zepbound: $299/$399/$449 by dose (LillyDirect; ~$350 TrumpRx). Wegovy: $349 flat ($199 × 2 starter offer; $149 oral intro). Those are the real cash prices — list price is a fiction almost nobody pays.
Why did Hims & Hers stop compounded GLP-1s?
Regulatory pressure: after the shortage resolution, FDA warning letters (≈30 in Feb 2026) and a DOJ referral, Hims closed its compounded GLP-1 program to new patients and went brand-only for new starts in March 2026 — part of a market-wide pivot our legal guide tracks.